INBX
Price
$92.50
Change
-$1.04 (-1.11%)
Updated
Jun 12, 12:53 PM (EDT)
Capitalization
1.37B
68 days until earnings call
Intraday BUY SELL Signals
SGMT
Price
$6.58
Change
+$0.15 (+2.33%)
Updated
Jun 12, 01:52 PM (EDT)
Capitalization
397.06M
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INBX vs SGMT

Header iconINBX vs SGMT Comparison
Open Charts INBX vs SGMTBanner chart's image
INBX vs SGMT Comparison Chart in %
View a ticker or compare two or three
VS
INBX vs. SGMT commentary
Jun 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a Hold and SGMT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 12, 2026
Stock price -- (INBX: $93.42 vs. SGMT: $6.43)
Brand notoriety: INBX and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 73% vs. SGMT: 41%
Market capitalization -- INBX: $1.37B vs. SGMT: $397.06M
INBX [@Biotechnology] is valued at $1.37B. SGMT’s [@Biotechnology] market capitalization is $397.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $112.95B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 1 FA rating(s) are green whileSGMT’s FA Score has 0 green FA rating(s).

  • INBX’s FA Score: 1 green, 4 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, INBX is a better buy in the long-term than SGMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 3 TA indicator(s) are bullish while SGMT’s TA Score has 4 bullish TA indicator(s).

  • INBX’s TA Score: 3 bullish, 7 bearish.
  • SGMT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SGMT is a better buy in the short-term than INBX.

Price Growth

INBX (@Biotechnology) experienced а +2.38% price change this week, while SGMT (@Biotechnology) price change was -8.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.19%. For the same industry, the average monthly price growth was +87.05%, and the average quarterly price growth was +1971.74%.

Reported Earning Dates

INBX is expected to report earnings on Aug 19, 2026.

SGMT is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (-4.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($1.37B) has a higher market cap than SGMT($397M). INBX YTD gains are higher at: 18.253 vs. SGMT (8.615). SGMT has higher annual earnings (EBITDA): -48.74M vs. INBX (-114.82M). INBX has more cash in the bank: 162M vs. SGMT (105M). SGMT has less debt than INBX: SGMT (39K) vs INBX (181M). INBX has higher revenues than SGMT: INBX (1.3M) vs SGMT (0).
INBXSGMTINBX / SGMT
Capitalization1.37B397M345%
EBITDA-114.82M-48.74M236%
Gain YTD18.2538.615212%
P/E Ratio0.20N/A-
Revenue1.3M0-
Total Cash162M105M154%
Total Debt181M39K464,103%
TECHNICAL ANALYSIS
Technical Analysis
INBXSGMT
RSI
ODDS (%)
Bearish Trend 5 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
82%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
INBX
Daily Signal:
Gain/Loss:
SGMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AASMX26.550.71
+2.75%
Thrivent Small Cap Stock A
PEQYX21.31N/A
N/A
Putnam Focused International Equity Y
JHQRX34.70N/A
N/A
JPMorgan Hedged Equity R6
LDVIX24.57N/A
N/A
AXS FTSE Vntr Cptl RetTrckr I
MIEFX20.17N/A
N/A
Matthews Emerging Markets Equity Ins

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+4.41%
AXON - INBX
48%
Loosely correlated
-0.31%
SNTI - INBX
39%
Loosely correlated
+2.83%
VCYT - INBX
37%
Loosely correlated
-1.56%
ARRY - INBX
37%
Loosely correlated
+9.00%
AMRN - INBX
34%
Loosely correlated
+1.29%
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with GOSS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
-1.08%
GOSS - SGMT
37%
Loosely correlated
+14.36%
VIR - SGMT
35%
Loosely correlated
+3.27%
CRBU - SGMT
34%
Loosely correlated
-7.26%
INBX - SGMT
33%
Loosely correlated
+4.41%
FTRE - SGMT
33%
Loosely correlated
+3.24%
More